Smoking cessation Aids, a product that Aids individuals in quitting smoking, essentially replaces smoking, though, without the harmful effects of smoking.
This report contains market size and forecasts of Smoking Cessation Aids in global, including the following market information:
- Global Smoking Cessation Aids Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Smoking Cessation Aids Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Smoking Cessation Aids companies in 2021 (%)
The global Smoking Cessation Aids market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NRT Inhaler Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Smoking Cessation Aids include Reckitt Benckiser, Pfizer, GlaxoSmithKline, Roche, Novartis, Johnson and Johnson, Bayer, Cipla and Takeda Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Smoking Cessation Aids manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Smoking Cessation Aids Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Smoking Cessation Aids Market Segment Percentages, by Type, 2021 (%)
- NRT Inhaler
- NRT Patch
- Spray
- Drug
- Electronic Cigarettes
- Other
Global Smoking Cessation Aids Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Smoking Cessation Aids Market Segment Percentages, by Application, 2021 (%)
- Pharmacy
- Supermarket
- Hospital
- Other
Global Smoking Cessation Aids Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Smoking Cessation Aids Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Smoking Cessation Aids revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Smoking Cessation Aids revenues share in global market, 2021 (%)
- Key companies Smoking Cessation Aids sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Smoking Cessation Aids sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Reckitt Benckiser
- Pfizer
- GlaxoSmithKline
- Roche
- Novartis
- Johnson and Johnson
- Bayer
- Cipla
- Takeda Pharmaceuticals
- NJOY
